-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Yangtze River Delta Alliance centralized procurement is a renewal project of the national centralized procurement
.
The results of 47 drugs to be selected will be announced, including 47 drugs in Anhui and Zhejiang provinces, and 38 varieties in Shanghai
.
.
The results of 47 drugs to be selected will be announced, including 47 drugs in Anhui and Zhejiang provinces, and 38 varieties in Shanghai
.
Judging from the number of varieties selected in the three provinces and cities, Huahai was selected 23 times, Qilu was selected 15 times, Kelun was selected 9 times, and Chenxin Pharmaceutical's dexmedetomidine hydrochloride injection was selected exclusively in the three provinces and cities
.
This time, the centralized procurement rules are relatively mild, and the price is not the only standard.
With their comprehensive strength, the leading pharmaceutical companies have obvious advantages!
.
This time, the centralized procurement rules are relatively mild, and the price is not the only standard.
With their comprehensive strength, the leading pharmaceutical companies have obvious advantages!
On March 17, the results of the centralized drug procurement (CSJ-YD2022-1) in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) alliance regions were announced
.
.
Announcement period: March 18, 2022 to March 22, 2022
Reception period: March 18, 2022 to March 22, 2022
According to the proposed selection table, there are 47 drugs to be selected in Anhui and Zhejiang provinces, and 38 drugs to be selected in Shanghai (atorvastatin, rosuvastatin, entecavir, olanzapine, cefuroxime axetil, Nine varieties of peridone, gefitinib, tenofovir disoproxil fumarate and montmorillonite powder were not selected in Shanghai)
.
.
Among them, Huahai, Qilu, Kelun, Jingxin, Chia Tai Tianqing and many other pharmaceutical companies were selected as the big winners of this centralized procurement
.
And Chenxin Pharmaceutical's dexmedetomidine hydrochloride injection was selected exclusively in Shanghai, Zhejiang and Anhui provinces and cities
.
.
And Chenxin Pharmaceutical's dexmedetomidine hydrochloride injection was selected exclusively in Shanghai, Zhejiang and Anhui provinces and cities
.
Previously (January 24, 2022), Shanghai Sunshine Pharmaceutical Purchasing Network released the "Documents on Centralized Drug Procurement in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) Alliance Regions (CSJ-YD2022-1)", and Shanghai, Zhejiang and Anhui reached an agreement to form a regional alliance , to form an alliance procurement working group to carry out centralized drug procurement in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) alliance regions
.
A total of 47 drugs were included, all of which were domestically sourced
.
.
A total of 47 drugs were included, all of which were domestically sourced
.
If the "unit comparable price" of a shortlisted drug meets one of the following conditions, the comprehensive score in the area where the enterprise
promises to supply the alliance will be calculated according to the "comprehensive evaluation index system" (see the table in Annex 4 for details), and the one with the highest score will be selected .
promises to supply the alliance will be calculated according to the "comprehensive evaluation index system" (see the table in Annex 4 for details), and the one with the highest score will be selected .
"Comparable price per unit" ≤ 1.
8 times the "comparable price per unit" of the shortlisted drugs of the same variety;
8 times the "comparable price per unit" of the shortlisted drugs of the same variety;
"Comparable price per unit" ≤ the average price of the same variety selected in the country
.
.
Price is no longer the only criterion
A major feature of the Yangtze River Delta Alliance's centralized procurement is the introduction of a "comprehensive evaluation index system" in the criteria for determining the drugs to be selected
.
The following figure can be recalled:
.
The following figure can be recalled:
This "comprehensive evaluation index system" is evaluated from the two dimensions of drugs and enterprises
.
Among them, the drug dimension includes 4 indicators of price, quality and efficacy, clinical applicability, and market share, while the enterprise dimension includes 6 indicators of quality management level, drug supply capability, social responsibility commitment, quality sampling, and credit evaluation
.
.
Among them, the drug dimension includes 4 indicators of price, quality and efficacy, clinical applicability, and market share, while the enterprise dimension includes 6 indicators of quality management level, drug supply capability, social responsibility commitment, quality sampling, and credit evaluation
.
Among them, points will be deducted for "unqualified or recalled quality sampling at the provincial level and above from 2019 to 2020" and "untrustworthy behavior in the list of untrustworthy items in the list of untrustworthy recruitment and procurement in the alliance area"
.
.
The Yangtze River Delta Alliance centralized procurement is a renewal project of the national centralized procurement
.
The results of 47 drugs to be selected will be announced, including 47 drugs in Anhui and Zhejiang provinces, and 38 varieties in Shanghai
.
.
The results of 47 drugs to be selected will be announced, including 47 drugs in Anhui and Zhejiang provinces, and 38 varieties in Shanghai
.
Judging from the number of varieties selected in the three provinces and cities, Huahai was selected 23 times, Qilu was selected 15 times, Kelun was selected 9 times, and Chenxin Pharmaceutical's dexmedetomidine hydrochloride injection was selected exclusively in the three provinces and cities
.
This time, the centralized procurement rules are relatively mild, and the price is not the only standard.
With their comprehensive strength, the leading pharmaceutical companies have obvious advantages!
.
This time, the centralized procurement rules are relatively mild, and the price is not the only standard.
With their comprehensive strength, the leading pharmaceutical companies have obvious advantages!
On March 17, the results of the centralized drug procurement (CSJ-YD2022-1) in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) alliance regions were announced
.
.
Announcement period: March 18, 2022 to March 22, 2022
Reception period: March 18, 2022 to March 22, 2022
According to the proposed selection table, there are 47 drugs to be selected in Anhui and Zhejiang provinces, and 38 drugs to be selected in Shanghai (atorvastatin, rosuvastatin, entecavir, olanzapine, cefuroxime axetil, Nine varieties of peridone, gefitinib, tenofovir disoproxil fumarate and montmorillonite powder were not selected in Shanghai)
.
.
Among them, Huahai, Qilu, Kelun, Jingxin, Chia Tai Tianqing and many other pharmaceutical companies were selected as the big winners of this centralized procurement
.
And Chenxin Pharmaceutical's dexmedetomidine hydrochloride injection was selected exclusively in Shanghai, Zhejiang and Anhui provinces and cities
.
.
And Chenxin Pharmaceutical's dexmedetomidine hydrochloride injection was selected exclusively in Shanghai, Zhejiang and Anhui provinces and cities
.
Previously (January 24, 2022), Shanghai Sunshine Pharmaceutical Purchasing Network released the "Documents on Centralized Drug Procurement in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) Alliance Regions (CSJ-YD2022-1)", and Shanghai, Zhejiang and Anhui reached an agreement to form a regional alliance , to form an alliance procurement working group to carry out centralized drug procurement in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) alliance regions
.
A total of 47 drugs were included, all of which were domestically sourced
.
.
A total of 47 drugs were included, all of which were domestically sourced
.
If the "unit comparable price" of a shortlisted drug meets one of the following conditions, the comprehensive score in the area where the enterprise
promises to supply the alliance will be calculated according to the "comprehensive evaluation index system" (see the table in Annex 4 for details), and the one with the highest score will be selected .
promises to supply the alliance will be calculated according to the "comprehensive evaluation index system" (see the table in Annex 4 for details), and the one with the highest score will be selected .
"Comparable price per unit" ≤ 1.
8 times the "comparable price per unit" of the shortlisted drugs of the same variety;
8 times the "comparable price per unit" of the shortlisted drugs of the same variety;
"Comparable price per unit" ≤ the average price of the same variety selected in the country
.
.
Price is no longer the only criterion
A major feature of the Yangtze River Delta Alliance's centralized procurement is the introduction of a "comprehensive evaluation index system" in the criteria for determining the drugs to be selected
.
The following figure can be recalled:
.
The following figure can be recalled:
This "comprehensive evaluation index system" is evaluated from the two dimensions of drugs and enterprises
.
Among them, the drug dimension includes 4 indicators of price, quality and efficacy, clinical applicability, and market share, while the enterprise dimension includes 6 indicators of quality management level, drug supply capability, social responsibility commitment, quality sampling, and credit evaluation
.
.
Among them, the drug dimension includes 4 indicators of price, quality and efficacy, clinical applicability, and market share, while the enterprise dimension includes 6 indicators of quality management level, drug supply capability, social responsibility commitment, quality sampling, and credit evaluation
.
Among them, points will be deducted for "unqualified or recalled quality sampling at the provincial level and above from 2019 to 2020" and "untrustworthy behavior in the list of untrustworthy items in the list of untrustworthy recruitment and procurement in the alliance area"
.
.
The Yangtze River Delta Alliance centralized procurement is a renewal project of the national centralized procurement
.
The results of 47 drugs to be selected will be announced, including 47 drugs in Anhui and Zhejiang provinces, and 38 varieties in Shanghai
.
.
The results of 47 drugs to be selected will be announced, including 47 drugs in Anhui and Zhejiang provinces, and 38 varieties in Shanghai
.
Judging from the number of varieties selected in the three provinces and cities, Huahai was selected 23 times, Qilu was selected 15 times, Kelun was selected 9 times, and Chenxin Pharmaceutical's dexmedetomidine hydrochloride injection was selected exclusively in the three provinces and cities
.
This time, the centralized procurement rules are relatively mild, and the price is not the only standard.
With their comprehensive strength, the leading pharmaceutical companies have obvious advantages!
.
This time, the centralized procurement rules are relatively mild, and the price is not the only standard.
With their comprehensive strength, the leading pharmaceutical companies have obvious advantages!
On March 17, the results of the centralized drug procurement (CSJ-YD2022-1) in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) alliance regions were announced
.
Procurement of medicines and medicines _.
Announcement period: March 18, 2022 to March 22, 2022
Reception period: March 18, 2022 to March 22, 2022
According to the proposed selection table, there are 47 drugs to be selected in Anhui and Zhejiang provinces, and 38 drugs to be selected in Shanghai (atorvastatin, rosuvastatin, entecavir, olanzapine, cefuroxime axetil, Nine varieties of peridone, gefitinib, tenofovir disoproxil fumarate and montmorillonite powder were not selected in Shanghai)
.
.
Among them, Huahai, Qilu, Kelun, Jingxin, Chia Tai Tianqing and many other pharmaceutical companies were selected as the big winners of this centralized procurement
.
And Chenxin Pharmaceutical's dexmedetomidine hydrochloride injection was selected exclusively in Shanghai, Zhejiang and Anhui provinces and cities
.
.
And Chenxin Pharmaceutical's dexmedetomidine hydrochloride injection was selected exclusively in Shanghai, Zhejiang and Anhui provinces and cities
.
Previously (January 24, 2022), Shanghai Sunshine Pharmaceutical Purchasing Network released the "Documents on Centralized Drug Procurement in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) Alliance Regions (CSJ-YD2022-1)", and Shanghai, Zhejiang and Anhui reached an agreement to form a regional alliance , to form an alliance procurement working group to carry out centralized drug procurement in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) alliance regions
.
A total of 47 drugs were included, all of which were domestically sourced
.
medicine medicine medicine.
A total of 47 drugs were included, all of which were domestically sourced
.
If the "unit comparable price" of a shortlisted drug meets one of the following conditions, the comprehensive score in the area where the enterprise
promises to supply the alliance will be calculated according to the "comprehensive evaluation index system" (see the table in Annex 4 for details), and the one with the highest score will be selected .
enterprise enterprise enterprisepromises to supply the alliance will be calculated according to the "comprehensive evaluation index system" (see the table in Annex 4 for details), and the one with the highest score will be selected .
"Comparable price per unit" ≤ 1.
8 times the "comparable price per unit" of the shortlisted drugs of the same variety;
8 times the "comparable price per unit" of the shortlisted drugs of the same variety;
"Comparable price per unit" ≤ the average price of the same variety selected in the country
.
.
Price is no longer the only criterion
Price is no longer the only standard standard A major feature of the Yangtze River Delta Alliance's centralized procurement is the introduction of a "comprehensive evaluation index system" in the criteria for determining the drugs to be selected
.
The following figure can be recalled:
.
The following figure can be recalled:
This "comprehensive evaluation index system" is evaluated from the two dimensions of drugs and enterprises
.
Among them, the drug dimension includes 4 indicators of price, quality and efficacy, clinical applicability, and market share, while the enterprise dimension includes 6 indicators of quality management level, drug supply capability, social responsibility commitment, quality sampling, and credit evaluation
.
.
Among them, the drug dimension includes 4 indicators of price, quality and efficacy, clinical applicability, and market share, while the enterprise dimension includes 6 indicators of quality management level, drug supply capability, social responsibility commitment, quality sampling, and credit evaluation
.
Among them, points will be deducted for "unqualified or recalled quality sampling at the provincial level and above from 2019 to 2020" and "untrustworthy behavior in the list of untrustworthy items in the list of untrustworthy recruitment and procurement in the alliance area"
.
.
